We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
701
PUT
Apple
AAPL
$4.43T
$15K ﹤0.01%
+62
New +$14K
ACHV icon
702
Achieve Life Sciences
ACHV
$723M
$15K ﹤0.01%
+5,000
New +$13.7K
CSGP icon
703
PUT
CoStar Group
CSGP
$12.7B
$15K ﹤0.01%
182
– –
ERC
704
Allspring Multi-Sector Income Fund
ERC
$259M
$15K ﹤0.01%
1,600
– –
HOOD icon
705
PUT
Robinhood
HOOD
$88.7B
$15K ﹤0.01%
110
-70
-39% -$7.63K
NXDR
706
Nextdoor Holdings
NXDR
$998M
$15K ﹤0.01%
7,500
-2,500
-25% -$4.85K
SFNC icon
707
Simmons First National
SFNC
$3.47B
$15K ﹤0.01%
800
– –
TEAM icon
708
Atlassian
TEAM
$39.7B
$15K ﹤0.01%
97
-737
-88% -$133K
VTYX
709
DELISTED
Ventyx Biosciences
VTYX
$15K ﹤0.01%
5,000
-2,500
-33% -$6.62K
WAY
710
Waystar Holding Corp
WAY
$4.7B
$15K ﹤0.01%
+400
New +$14.8K
ALTI icon
711
AlTi Global
ALTI
$464M
$14K ﹤0.01%
+4,000
New +$16.6K
AVIR icon
712
Atea Pharmaceuticals
AVIR
$413M
$14K ﹤0.01%
5,000
– –
CLGN icon
713
CollPlant Biotechnologies
CLGN
$5.86M
$14K ﹤0.01%
+5,250
New +$12.5K
EMD
714
Western Asset Emerging Markets Debt Fund
EMD
$610M
$14K ﹤0.01%
1,400
– –
GDO
715
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
$14K ﹤0.01%
1,200
– –
NCNA
716
NuCana
NCNA
$6.12M
$14K ﹤0.01%
+3,226
New +$20.7K
PRE icon
717
Prenetics Global
PRE
$331M
$14K ﹤0.01%
+1,053
New +$9.23K
TGTX icon
718
TG Therapeutics
TGTX
$7.37B
$14K ﹤0.01%
+409
New +$13.5K
TSHA icon
719
Taysha Gene Therapies
TSHA
$1.95B
$14K ﹤0.01%
+4,289
New +$12.1K
WDI
720
Western Asset Diversified Income Fund
WDI
$687M
$14K ﹤0.01%
1,000
– –
WSC icon
721
WillScot Mobile Mini Holdings
WSC
$4.08B
$14K ﹤0.01%
+682
New +$17.6K
BEAGR
722
Bold Eagle Acquisition Corp Right
BEAGR
$14K ﹤0.01%
+52,126
New +$14.8K
AKRO
723
DELISTED
Akero Therapeutics
AKRO
$13K ﹤0.01%
293
-242
-45% -$11.7K
ARKK icon
724
PUT
ARK Innovation ETF
ARKK
$6.49B
$13K ﹤0.01%
160
-15
-9% -$1.15K
SRTA
725
Strata Critical Medical Inc
SRTA
$526M
$13K ﹤0.01%
+2,730
New +$12.1K
27 28
29
30 31

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.